Biotechnology Market Development: Global Trends and the Place of Russia

Abstract

The article deals with the development, functioning and regulation of the biopharmaceutical market in Russia and in the world. The statistics of investments in research and development in the private and public sectors are presented, it is concluded that the leading countries over the past ten years have gradually increased the growth rates of investments in R&D and built technological chains in various countries of the world. The data show that the structure and configuration of production, technology and sales chains in the world economy has changed over ten years, if the United States dominated earlier, then from the beginning of 2010 China has become an active player in this process. Using the example of the largest global biotechnology corporations, the importance of investments in research and development and their relationship with income levels is shown. According to the calculations, Russian pharmaceutical companies are seriously lagging behind their competitors in terms of key economic indicators.